Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2006 | 12-2005 | 09-2005 | 06-2005 | 03-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,634 | -15,297 | -12,262 | -9,271 | -7,140 |
| Depreciation Amortization | 248 | 799 | 635 | 406 | 191 |
| Accounts receivable | -145 | 153 | 154 | -2,088 | -25 |
| Other Working Capital | -983 | -1,229 | -1,648 | -2,787 | -36 |
| Other Operating Activity | 684 | 3,267 | 3,265 | 5,505 | 3,425 |
| Operating Cash Flow | $-2,829 | $-12,308 | $-9,856 | $-8,235 | $-3,585 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -12,000 | N/A | N/A | N/A | N/A |
| PPE Investments | -35 | -287 | -282 | -235 | -218 |
| Net Acquisitions | N/A | -2,341 | -2,341 | -2,341 | -2,341 |
| Purchase Sale Intangibles | -88 | -448 | -302 | -178 | -82 |
| Other Investing Activity | -88 | -448 | -302 | -178 | -82 |
| Investing Cash Flow | $-12,123 | $-3,076 | $-2,926 | $-2,754 | $-2,641 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 62 | 15,305 | 289 | 289 | 289 |
| Dividend Paid | -65 | -614 | -420 | -281 | -143 |
| Financing Cash Flow | $-2 | $14,691 | $-131 | $8 | $145 |
| Exchange Rate Effect | 8 | -30 | N/A | N/A | N/A |
| Beginning Cash Position | 17,167 | 17,890 | 17,890 | 17,890 | 17,890 |
| End Cash Position | 2,220 | 17,167 | 4,977 | 6,909 | 11,810 |
| Net Cash Flow | $-14,946 | $-723 | $-12,913 | $-10,981 | $-6,080 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,829 | -12,308 | -9,856 | -8,235 | -3,585 |
| Capital Expenditure | -35 | -287 | -282 | -235 | -218 |
| Free Cash Flow | -2,865 | -12,595 | -10,138 | -8,470 | -3,802 |